[Corrigendum] Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway
- PMID: 38994771
- PMCID: PMC11267495
- DOI: 10.3892/or.2024.8774
[Corrigendum] Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway
Abstract
Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, for the scratch‑wound assay experiments shown in Fig. 3C, two images appeared to overlap [specifically, the '0 h / Control' and 0 h / OP‑B (5 μmol/l) data panels], albeit with different magnification and after a 180° rotation. The authors have examined their original data, and realize that an inadvertent error was made in assembling the images in the figure; specifically, the images of 5 and 10 μmol/l OP‑B treatment for 0 h were both misused. The corrected version of Fig. 3, showing all the correct data for Fig. 3C, is shown on the next page. Note that these errors did not affect the overall conclusions reported in the paper. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this. They also apologize to the readership for any inconvenience caused. [Oncology Reports 40: 1339‑1347, 2018; DOI: 10.3892/or.2018.6531].
Keywords: EphA2/Akt; Ophiopogonin B; adenocarcinoma; angiogenesis; epithelial‑mesenchymal transition; metastasis.
Figures

Erratum for
-
Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway.Oncol Rep. 2018 Sep;40(3):1339-1347. doi: 10.3892/or.2018.6531. Epub 2018 Jun 27. Oncol Rep. 2018. PMID: 29956803 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous